Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials-Reference-Cited by-同舟云学术

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

Published:2021-08 Issue:8 Volume:21 Page:1107-1119
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Yang Shilong,Li Yan,Dai Lianpan,Wang Jianfeng,He Peng,Li Changgui,Fang Xin,Wang Chenfei,Zhao Xiang,Huang Enqi,Wu Changwei,Zhong Zaixin,Wang Fengze,Duan Xiaomin,Tian Siyu,Wu Lili,Liu Yan,Luo Yi,Chen Zhihai,Li Fangjun,Li Junhua,Yu Xian,Ren Hong,Liu Lihong,Meng Shufang,Yan Jinghua,Hu Zhongyu,Gao Lidong,Gao George F

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference29 articles.

1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med,2020

2. A distinct name is needed for the new coronavirus;Jiang;Lancet,2020

3. Description of the first strain of 2019-nCoV, C-Tan-nCoV Wuhan strain—National Pathogen Resource Center, China, 2020;Wei;China CDC Wkly,2020

4. Viral targets for vaccines against COVID-19;Dai;Nat Rev Immunol,2021

5. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

Cited by 374 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

2. Amyloidogenesis of SARS-CoV-2 delta plus and omicron variants receptor-binding domain (RBD): impact of SUMO fusion tag;Biotechnology Letters;2024-08-25

3. Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac®) as a Heterologous Booster Dose against COVID-19 in Indonesian Adolescents;Vaccines;2024-08-22

4. Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China;Human Vaccines & Immunotherapeutics;2024-08-22

5. Immunological storm and multiple organ damage by COVID-19;Medicine in Omics;2024-08